WP
DGX icon

Woodline Partners’s Quest Diagnostics DGX Stock Holding History

Woodline Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Sell
485,841
-107,903
-18% -$21.2M 0.32% 67
2026
Q1 		$116M Buy
593,744
+252,372
+74% +$49M 0.44% 36
2025
Q4 		$59.2M Buy
341,372
+223,936
+191% +$40.8M 0.23% 103
2025
Q3 		$22.4M Sell
117,436
-31,037
-21% -$5.51M 0.11% 254
2025
Q2 		$26.7M Sell
148,473
-232,227
-61% -$40.3M 0.14% 220
2025
Q1 		$64.4M Sell
380,700
-123,896
-25% -$20.4M 0.42% 44
2024
Q4 		$76.1M Buy
504,596
+31,535
+7% +$4.9M 0.51% 33
2024
Q3 		$73.4M Sell
473,061
-310,842
-40% -$46.4M 0.62% 29
2024
Q2 		$107M Buy
783,903
+651,672
+493% +$89.2M 1.02% 11
2024
Q1 		$17.6M Buy
+132,231
New +$17.2M 0.16% 189
2022
Q4 		– Sell
-26,408
Closed -$3.24M – 776
2022
Q3 		$3.24M Sell
26,408
-29,425
-53% -$3.88M 0.05% 373
2022
Q2 		$7.42M Buy
+55,833
New +$7.61M 0.11% 208
2020
Q4 		– Sell
-142,339
Closed -$16.3M – 238
2020
Q3 		$16.3M Sell
142,339
-51,505
-27% -$6.09M 0.53% 51
2020
Q2 		$22.1M Buy
+193,844
New +$20.6M 0.88% 43

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Woodline Partners's DGX Position: Q2 2026 in Review

Woodline Partners reduced its Quest Diagnostics (DGX) stake by 18% in Q2 2026, selling an estimated $21.2M and leaving 485,841 shares worth $103M. The position accounts for 0.32% of the portfolio, ranked #67.

Woodline Partners first reported a position in DGX in Q2 2020 and has held it in 14 quarters since. The position peaked at $116M in Q1 2026. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Woodline Partners held 485,841 shares of Quest Diagnostics worth $103M as of Q2 2026.
  • Woodline Partners sold 107,903 Quest Diagnostics shares in Q2 2026, an estimated $21.2M.
  • Quest Diagnostics made up 0.32% of Woodline Partners's portfolio in Q2 2026, its #67 holding.
  • Woodline Partners first reported a position in Quest Diagnostics in Q2 2020 and has held it in 14 quarters since.
  • Woodline Partners's Quest Diagnostics position peaked at $116M in Q1 2026.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.